US 11266724
Modified factor VII polypeptides for subcutaneous administration and on-demand treatment
granted A61KA61K2039/505A61K31/7105
Quick answer
US patent 11266724 (Modified factor VII polypeptides for subcutaneous administration and on-demand treatment) held by Catalyst Biosciences, Inc. expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Catalyst Biosciences, Inc.
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K31/7105, A61K38/4846, A61K39/3955